These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28554311)

  • 1. The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.
    Penke B; Fulop L; Szucs M; Frecska E
    Curr Neuropharmacol; 2018; 16(1):97-116. PubMed ID: 28554311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.
    Weng TY; Tsai SA; Su TP
    J Biomed Sci; 2017 Sep; 24(1):74. PubMed ID: 28917260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sigma-1 receptor chaperone as an inter-organelle signaling modulator.
    Su TP; Hayashi T; Maurice T; Buch S; Ruoho AE
    Trends Pharmacol Sci; 2010 Dec; 31(12):557-66. PubMed ID: 20869780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk.
    Cheng D; Lei ZG; Chu K; Lam OJH; Chiang CY; Zhang ZJ
    Alzheimers Res Ther; 2024 May; 16(1):95. PubMed ID: 38693554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor?
    Delprat B; Crouzier L; Su TP; Maurice T
    Adv Exp Med Biol; 2020; 1131():699-718. PubMed ID: 31646531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease.
    Cai Y; Yang L; Niu F; Liao K; Buch S
    Adv Exp Med Biol; 2017; 964():163-175. PubMed ID: 28315271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration.
    Ruscher K; Wieloch T
    J Pharmacol Sci; 2015 Jan; 127(1):30-5. PubMed ID: 25704015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.
    Tsai SY; Pokrass MJ; Klauer NR; De Credico NE; Su TP
    Expert Opin Ther Targets; 2014 Dec; 18(12):1461-76. PubMed ID: 25331742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction.
    Hayashi T; Fujimoto M
    Mol Pharmacol; 2010 Apr; 77(4):517-28. PubMed ID: 20053954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival.
    Mori T; Hayashi T; Hayashi E; Su TP
    PLoS One; 2013; 8(10):e76941. PubMed ID: 24204710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.
    Hayashi T; Su TP
    Cell; 2007 Nov; 131(3):596-610. PubMed ID: 17981125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.
    Su TP; Su TC; Nakamura Y; Tsai SY
    Trends Pharmacol Sci; 2016 Apr; 37(4):262-278. PubMed ID: 26869505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigma-1 Receptors Fine-Tune the Neuronal Networks.
    Tsai SA; Su TP
    Adv Exp Med Biol; 2017; 964():79-83. PubMed ID: 28315266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain.
    Wang SM; Goguadze N; Kimura Y; Yasui Y; Pan B; Wang TY; Nakamura Y; Lin YT; Hogan QH; Wilson KL; Su TP; Wu HE
    Mol Neurobiol; 2021 Jun; 58(6):2523-2541. PubMed ID: 33459966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases.
    Wu NH; Ye Y; Wan BB; Yu YD; Liu C; Chen QJ
    Mol Neurobiol; 2021 Nov; 58(11):5649-5666. PubMed ID: 34383254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands.
    Bogár F; Fülöp L; Penke B
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigma-1 Receptor as a Protective Factor for Diabetes-Associated Cognitive Dysfunction via Regulating Astrocytic Endoplasmic Reticulum-Mitochondrion Contact and Endoplasmic Reticulum Stress.
    Du M; Jiang T; He S; Cheng B; Zhang X; Li L; Yang L; Gao W; Li Y; Wang Q
    Cells; 2023 Jan; 12(1):. PubMed ID: 36611988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor.
    Fujimoto M; Hayashi T; Urfer R; Mita S; Su TP
    Synapse; 2012 Jul; 66(7):630-9. PubMed ID: 22337473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of a novel sigma-1 receptor agonist is associated with reduced endoplasmic reticulum stress in stroke male mice.
    Morihara R; Yamashita T; Liu X; Nakano Y; Fukui Y; Sato K; Ohta Y; Hishikawa N; Shang J; Abe K
    J Neurosci Res; 2018 Oct; 96(10):1707-1716. PubMed ID: 30102416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases.
    Munguia-Galaviz FJ; Miranda-Diaz AG; Cardenas-Sosa MA; Echavarria R
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.